| 2026-08-11 | sam | 6505--Alnylam Pharmaceuticals 09/01/2026 - 08/31/2031 | ALNYLAM PHARMACEUTICALS, | $387.8M | 1.0 |
| 2026-07-30 | sam | 6505--Assertio Specialty Pharmaceuticals, LLC (PENDING PROPO | ASSERTIO SPECIALTY PHARMA | $14.0M | 0.8 |
| 2026-07-24 | sam | 6505--Budesonide/Formoterol INH | MYLAN PHARMACEUTICALS INC | $436.5M | 1.0 |
| 2026-07-23 | sam | 6505--Lab Supplies | Radiopharm | 5-Year Indefinite Deliver | CARDINAL HEALTH 414, LLC | $3.6M | 0.6 |
| 2026-07-13 | sam | Charleston CMOP-CARBOXYMETHYLCELLULOSE NA 0.25% OPH SOLN 15M | D'S VENTURES, LLC | $61K | 0.1 |
| 2026-07-10 | sam | 6505--Alkermes, Inc August 01, 2026 - July 31, 2031 | ALKERMES, INC. | $1.68B | 1.0 |
| 2026-07-03 | sam | Chemistry, Manufacturing and Controls and Related Services f | SRI INTERNATIONAL | $49.9M | 0.9 |
| 2026-01-15 | usaspending | 75N93026F00001 | SRI INTERNATIONAL | $87K | 0.1 |
| 2025-09-29 | usaspending | 49100425F0110 | SRI INTERNATIONAL | $3.6M | 0.5 |
| 2023-09-01 | usaspending | 49100423F0202 | SRI INTERNATIONAL | $1.0M | 0.2 |
| 2022-01-03 | usaspending | 91990022C0008 | SRI INTERNATIONAL | $19.8M | 0.6 |
| 2021-02-01 | usaspending | SPE7L121F172D | SRI INTERNATIONAL | $60.3M | 0.7 |